Treatment of Advanced Gastrointestinal Adenocarcinoma in a Phase I/II trial with modified allogeneic MSC_apceth_111

Trial Profile

Treatment of Advanced Gastrointestinal Adenocarcinoma in a Phase I/II trial with modified allogeneic MSC_apceth_111

Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 29 Mar 2017

At a glance

  • Drugs Agenmestencel-T (Primary) ; Ganciclovir
  • Indications Cholangiocarcinoma; Colorectal cancer; Gastric cancer; Pancreatic cancer
  • Focus Adverse reactions; First in man
  • Acronyms TREAT-ALL 1
  • Sponsors Apceth
  • Most Recent Events

    • 25 Mar 2017 Status changed from suspended to discontinued.
    • 02 Mar 2016 Status changed from recruiting to suspended as reported by European Clinical Trials Database record.
    • 30 Mar 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top